| IGFBP7 |  | |
---|---|---|---|
 | Methylation | Unmenthylation | p.value |
Gender | Â | Â | 0.444 |
Male | 22 | 13 | Â |
Female | 9 | 3 | Â |
Age at Diagnosis | 54.3 ± 10.7 | 50.9 ± 7.6 | 0.267 |
Tumor Size (mm) | 30.2 ± 13.8 | 27.1 ± 11.5 | 0.451 |
Invasion Depth (mm) | 17.3 ± 10.3 | 9.7 ± 6.4 | 0.030* |
AJCC Stage | Â | Â | 0.437 |
Early (I-II) | 10 | 7 | Â |
Locally Advanced (III-IVB) | 21 | 9 | Â |
Perineural Infiltration | Â | Â | 0.458 |
Yes | 19 | 8 | Â |
No | 12 | 8 | Â |
Lymphovascular Permeation | Â | Â | 0.458 |
Yes | 19 | 8 | Â |
No | 12 | 8 | Â |
Extracapsular Spread | Â | Â | 0.444 |
Yes | 9 | 3 | Â |
No | 22 | 13 | Â |
Postoperative Radiotherapy | Â | Â | 0.236 |
Yes | 21 | 8 | Â |
No | 10 | 8 | Â |
Adjuvant Chemotherapy | Â | Â | 0.357 |
Yes | 14 | 5 | Â |
No | 17 | 11 | Â |
Loco-regional Recurrence | Â | Â | 0.011* |
Yes | 13 | 1 | Â |
No | 18 | 15 | Â |
Distant Metastasis | Â | Â | 0.133 |
Yes | 4 | 12 | Â |
No | 27 | 4 | Â |
Cancer Sequence | Â | Â | 0.029* |
First Cancer | 20 | 15 | Â |
Second Primary | 11 | 1 | Â |